Internal Server Error

General Proximity - About the company

General Proximity is a seed company based in San Francisco (United States), founded in 2023 by Armand B Cognetta III. It operates as a Developer of next generation of induced-proximity medicines. General Proximity has raised $16M in funding. The company has 2604 active competitors, including 888 funded and 621 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Tango Therapeutics and Elicio.

Company Details

Developer of next generation of induced-proximity medicines. The company uses the OmniTAC drug discovery engine which yields molecules that co-opt existing cellular machinery to overcome exigent therapeutic challenges for oncology indications.
Social
X
Email ID
*****@generalproximity.bio
Key Metrics
Founded Year
2023
Location
San Francisco, United States
Stage
Seed
Total Funding
$16M in 2 rounds
Latest Funding Round
Ranked
Employee Count
25 as on Sep 30, 2026
Similar Companies
Sign up to download General Proximity's company profile

General Proximity's funding and investors

General Proximity has raised a total funding of $16M over 2 rounds. Its first funding round was on Jan 04, 2025. Its latest funding round was a Seed round on May 04, 2026 for $*****. 1 investor participated in its latest round. General Proximity has 9 institutional investors and 5 angel investors.

Here is the list of recent funding rounds of General Proximity:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 04, 2026
7260891
Seed
8418297
2965528
8100447
3820922
Jan 04, 2025
7320649
Seed
9370392
3398339
3040200
lockAccess funding benchmarks and valuations. Sign up today!

General Proximity's founders and board of directors

Founder? Claim Profile
The founders of General Proximity is Armand B Cognetta III. Armand B Cognetta III is the CEO of General Proximity.
Here are the details of General Proximity's key team members:

General Proximity's employee count trend

General Proximity has 25 employees as of Sep 26. Here is General Proximity's employee count trend over the years:
Employee count trend for General Proximity
lockUncover General Proximity's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

General Proximity's Competitors and alternates

Top competitors of General Proximity include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Here is the list of Top 10 competitors of General Proximity, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of novel biopharmaceutical medicines for unmet medical needs
$265M
82/100
2nd
Logo for Tango Therapeutics
Tango Therapeutics
2017, Cambridge (United States), Public
Developer of drugs for the treatment of cancer
$165M
72/100
3rd
Logo for Elicio
Elicio
2012, Cambridge (United States), Public
Developer of vaccines for treating cancer
$47.4M
72/100
4th
Logo for Immuneel
Immuneel
2018, Bengaluru (India), Series B
Developer of T-cell therapies for the treatment of cancer
$49.8M
71/100
5th
Logo for BioNTech
BioNTech
2008, Mainz (Germany), Public
Developer of immunotherapeutics for the treatment of cancer and other diseases
$861M
71/100
6th
Logo for Erasca
Erasca
2018, San Diego (United States), Public
Developer of small molecule based therapeutics for cancer
$300M
71/100
7th
Logo for Deciphera
Deciphera
2003, Waltham (United States), Acquired
Developer of type 2 kinase inhibitors for treating cancer
$173M
70/100
8th
Logo for Ideaya Biosciences
Ideaya Biosciences
2015, San Francisco (United States), Public
Developer of oncology-focused precision medicine using molecular diagnostics
$157M
70/100
9th
Logo for Sana Biotechnology
Sana Biotechnology
2018, Seattle (United States), Public
Developer of engineered cell therapies for treating various human diseases
$821M
69/100
10th
Logo for Halozyme
Halozyme
1999, San Diego (United States), Public
Developer of drug delivery technologies for the treatment of various diseases
-
69/100
317th
Logo for General Proximity
General Proximity
2023, San Francisco (United States), Seed
Developer of next generation of induced-proximity medicines
$16M
53/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on General Proximity's competitors? Click here to see the top ones

General Proximity's Investments and acquisitions

General Proximity has made no investments or acquisitions yet.

Reports related to General Proximity

Here is the latest report on General Proximity's sector:

News related to General Proximity

Media has covered General Proximity for 1 event in last 1 year.
•
General Proximity Receives InvestmentFinSMEs•May 04, 2026•General Proximity
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about General Proximity

Explore our recently published companies
  • TransportHub - Mumbai based, 2016 founded, Early Stage company
  • Better Aid BD - Dhaka based, 2021 founded, Unfunded company
  • Mold-Tek - Hyderabad based, 1985 founded, Public company
  • Questin - Jaipur based, 2026 founded, Unfunded company
  • MealSync - Unfunded company
  • Provimedia - Bietigheim Bissingen based, 2007 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford